Wandercraft acquires Ekso Bionics and brings four medical exoskeletons under one roof
Image: Wandercraft / YouTube · video-thumbnail
Wandercraft announced on 1 October 2026 that it had acquired Ekso Bionics from a ChronoScale subsidiary, combining four medical exoskeletons.
French exoskeleton maker Wandercraft announced on 1 October 2026 that it had acquired Ekso Bionics from a subsidiary of ChronoScale Holdings, with signing and closing on the same day. The combined company sells four medical exoskeletons: Atalante X and EksoNR for clinical rehabilitation, and Eve and Indego for personal use.
The two companies say their rehabilitation systems are used for walking training in more than 700 rehabilitation and research centres worldwide. Wandercraft chief executive Matthieu Masselin presented the deal as a way to widen access to robotic mobility for people who cannot walk unaided. All four products remain supported.
The financial terms were not disclosed, and it is not yet clear how the product lines will be combined over time. The deal consolidates a small market in which few companies have reached clinical scale.
